Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol.

about

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol.

Item

http://www.wikidata.org/entity/Q42358420

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@en

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@nl

type

Item

label

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@en

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@nl

prefLabel

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@en

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@nl

P1476

Comparison of Insulin Detemir ...... nts on a Basal-Bolus Protocol.

@en

P2093

Chad Friece

http://www.w3.org/2001/XMLSchema#string

Darrell Newcomer

http://www.w3.org/2001/XMLSchema#string

Evangelina Castaneda

http://www.w3.org/2001/XMLSchema#string

Nicki Roderman

http://www.w3.org/2001/XMLSchema#string

Sondra Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Insulin detemir versus insulin glargine for type 2 diabetes mellitus

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Inpatient management of type 2 Diabetes Mellitus: Does choice of insulin regimen really matter?

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Review of insulin therapy and pen use in hospitalized patients.

Pathophysiology and management strategies for hyperglycemia for patients with acute illness during and following a hospital stay.

The past, present, and future of basal insulins.

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.

Non-inferiority of insulin glargine versus insulin detemir on blood glucose variability in type 1 diabetes patients: a multicenter, randomized, crossover study.

P31

scholarly article

P356

10.3390/PHARMACY5020022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28970434

http://www.w3.org/2001/XMLSchema#string

P932

5597147

http://www.w3.org/2001/XMLSchema#string